Published in PLoS One on September 13, 2010
Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth. Cancer Immunol Immunother (2014) 0.78
Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus. Oncol Rep (2011) 0.77
Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model. PLoS One (2016) 0.76
In Vitro and In Vivo Tumor Growth Inhibition by Glutathione Disulfide Liposomes. Cancer Growth Metastasis (2017) 0.75
Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail. Chin J Cancer (2012) 0.75
SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice. Oncotarget (2016) 0.75
The anti-hepatocellular carcinoma activity of Mel-P15 is mediated by natural killer cells. Oncol Lett (2017) 0.75
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Cancer immunotherapy: moving beyond current vaccines. Nat Med (2004) 17.61
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol (1996) 6.22
Treatment of metastatic melanoma: an overview. Oncology (Williston Park) (2009) 4.58
IL-17: prototype member of an emerging cytokine family. J Leukoc Biol (2002) 4.39
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? Eur J Cancer (2004) 3.46
NK cells and cancer immunosurveillance. Oncogene (2008) 2.34
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med (2000) 2.23
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity (1999) 2.06
In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res (2003) 1.81
Antitumor activity of IFN-lambda in murine tumor models. J Immunol (2006) 1.63
Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res (1998) 1.57
CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol (2000) 1.49
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol (1999) 1.45
Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res (2001) 1.44
Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med (2005) 1.35
Targeting telomerase for cancer therapeutics. Br J Cancer (2008) 1.35
Clinical implications of telomerase in cancer. Eur J Cancer (1997) 1.34
Cutaneous melanoma: available therapy for metastatic disease. Dermatol Ther (2006) 1.32
Anti-CTLA4 antibody-induced lupus nephritis. N Engl J Med (2009) 1.30
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci U S A (2000) 1.26
Synergy between tumor immunotherapy and antiangiogenic therapy. Blood (2003) 1.23
Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma (2003) 1.19
Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol (1988) 1.18
IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J Immunol (2004) 1.14
Cutaneous melanoma in the era of molecular profiling. Lancet (2009) 1.10
Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol (1995) 1.09
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. J Immunol (2002) 1.06
Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells. Cancer Res (2002) 1.05
Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology (2008) 1.05
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res (2001) 1.02
Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes. Clin Cancer Res (2003) 0.95
Multipeptide vaccination in cancer patients. Expert Opin Biol Ther (2009) 0.94
Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells. Cancer Res (2002) 0.92
Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Res (1987) 0.92
Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. Int J Cancer (2002) 0.90
Telomeres and telomerase as targets for cancer therapy. Cell Mol Life Sci (2007) 0.89
Malignant melanoma: current state of primary and adjuvant treatment. Crit Rev Oncol Hematol (2003) 0.88
A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide. Cancer Gene Ther (2007) 0.87
Cancer immunotherapy targeting the telomerase reverse transcriptase. Cell Mol Immunol (2006) 0.87
Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology (1995) 0.86
Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy. Cancer Gene Ther (2008) 0.85
Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings. Recent Pat Anticancer Drug Discov (2008) 0.85
In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells. J Immunol (2005) 0.84
Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res (1987) 0.83
Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. Int J Oncol (2005) 0.83
Medical management of melanoma. Surg Clin North Am (2003) 0.82
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials. J Clin Oncol (2001) 0.82
During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment. Immunology (2006) 0.81
Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats. Biochem Biophys Res Commun (2004) 0.79
Booster effect of interleukin-2 on natural killer 1.1+ cells stimulated by administration of macrophage colony-stimulating factor in mice. J Immunother (2003) 0.78
Vaccination: role in metastatic melanoma. Expert Rev Anticancer Ther (2006) 0.77
Biochemotherapy in metastatic melanoma: quo vadis? Melanoma Res (2005) 0.76
Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft. Cell Immunol (2000) 0.76
Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn (2012) 3.54
The main auxin biosynthesis pathway in Arabidopsis. Proc Natl Acad Sci U S A (2011) 2.87
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut (2011) 2.33
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res (2011) 2.08
Heterosis. Plant Cell (2010) 2.06
Locally injection of cell sheet fragments enhances new bone formation in mandibular distraction osteogenesis: a rabbit model. J Orthop Res (2013) 1.95
Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology (2011) 1.93
From a single-band metal to a high-temperature superconductor via two thermal phase transitions. Science (2011) 1.87
EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut (2011) 1.87
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res (2009) 1.76
N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer (2003) 1.75
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun (2009) 1.66
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun (2009) 1.61
MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol (2011) 1.53
MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell (2011) 1.46
Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem (2012) 1.43
Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology (2007) 1.40
Biological consequences of dosage dependent gene regulatory systems. Biochim Biophys Acta (2007) 1.39
Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer (2010) 1.34
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32
1-[2,2-Bis(1,3-benzimidazol-1-ylmeth-yl)-3-bromo-prop-yl]-1,3-benzimidazole. Acta Crystallogr Sect E Struct Rep Online (2011) 1.30
High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med (2010) 1.26
Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study. Proteomics (2003) 1.26
Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes (2003) 1.24
miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem (2010) 1.24
A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun (2002) 1.20
MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle (2012) 1.20
Epidemiological dynamics and phylogeography of influenza virus in southern China. J Infect Dis (2012) 1.16
Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol (2012) 1.15
Diabetes gene therapy: potential and challenges. Curr Gene Ther (2003) 1.15
Unraveling the genetic basis of hybrid vigor. Proc Natl Acad Sci U S A (2006) 1.11
Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest (2011) 1.11
Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma. J Natl Cancer Inst (2007) 1.08
Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics (2009) 1.08
Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Proteomics (2010) 1.07
Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev (2009) 1.07
MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta (2011) 1.04
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res (2009) 1.04
Hormone signaling in plant development. Curr Opin Plant Biol (2012) 1.03
MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box. J Biol Chem (2011) 1.02
Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett (2012) 1.02
EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling. Cancer Res (2006) 1.01
Inhibition of hepatitis B virus replication by stably expressed shRNA. Biochem Biophys Res Commun (2003) 0.99
The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases. J Biol Chem (2003) 0.98
A robust approach for blind detection of balanced chromosomal rearrangements with whole-genome low-coverage sequencing. Hum Mutat (2014) 0.96
The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomaterials (2009) 0.96
MuDR transposase increases the frequency of meiotic crossovers in the vicinity of a Mu insertion in the maize a1 gene. Genetics (2004) 0.96
Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation. Biochim Biophys Acta (2006) 0.95
Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir Ther (2005) 0.95
RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Lett (2010) 0.95
The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells. Biochem Pharmacol (2006) 0.95
Topological insulators and nematic phases from spontaneous symmetry breaking in 2D fermi systems with a quadratic band crossing. Phys Rev Lett (2009) 0.94
Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats. Curr Drug Metab (2012) 0.94
Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol Cancer Ther (2006) 0.94
Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics (2009) 0.93
Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics (2009) 0.93
Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. Int J Cancer (2013) 0.93
Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells. Cancer Res (2002) 0.92
Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. Int J Cancer (2008) 0.92
Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics (2007) 0.92
miRNA-mediated functional changes through co-regulating function related genes. PLoS One (2010) 0.91
Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/beta-catenin signaling pathway. Mol Cell Endocrinol (2009) 0.91
Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells. Cancer Lett (2008) 0.91
Iron-based superconductors: unity or diversity? Nat Mater (2008) 0.90
Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma. Int J Cancer (2009) 0.89
Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine. Vaccine (2011) 0.89
Post-transcriptional suppression of gene expression in Xenopus embryos by small interfering RNA. Nucleic Acids Res (2002) 0.89
Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA (2003) 0.88
An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers. PLoS One (2011) 0.88
Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression. Integr Cancer Ther (2010) 0.88
Enhancing bone formation by transplantation of a scaffold-free tissue-engineered periosteum in a rabbit model. Clin Oral Implants Res (2011) 0.87
Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn (2012) 0.87
Cancer immunotherapy targeting the telomerase reverse transcriptase. Cell Mol Immunol (2006) 0.87
MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2. Oncol Rep (2013) 0.87
The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas. J Pathol (2013) 0.87
The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat. Biomaterials (2009) 0.86
Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia. Life Sci (2008) 0.86
Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun (2004) 0.86
Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells. Biochem Biophys Res Commun (2009) 0.86
The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma. Carcinogenesis (2013) 0.86
Induction of apoptosis and inhibition of cell growth by developmental regulator hTBX5. Biochem Biophys Res Commun (2002) 0.86
Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. Biochem Biophys Res Commun (2003) 0.85
Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis. Apoptosis (2012) 0.85
[Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients]. Zhen Ci Yan Jiu (2010) 0.85
[Meta-analysis of the relationship between passive smoking population in China and lung cancer]. Zhongguo Fei Ai Za Zhi (2010) 0.84